...
首页> 外文期刊>Journal of Molecular and Cellular Cardiology >PKC beta II specifically regulates KCNQ1/KCNE1 channel membrane localization
【24h】

PKC beta II specifically regulates KCNQ1/KCNE1 channel membrane localization

机译:PKC Beta II专门调节KCNQ1 / KCNE1通道膜定位

获取原文
获取原文并翻译 | 示例

摘要

The slow voltage-gated potassium channel (IKs) is composed of the KCNQ1 and KCNE1 subunits and is one of the major repolarizing currents in the heart. Activation of protein kinase C (PKC) has been linked to cardiac arrhythmias. Although PKC has been shown to be a regulator of a number of cardiac channels, including IKs, little is known about regulation of the channel by specific isoforms of PKC. Here we studied the role of different PKC isoforms on IKs channel membrane localization and function. Our studies focused on PKC isoforms that translocate to the plasma membrane in response to Gq-coupled receptor (GqPCR) stimulation: PKC alpha, PKC beta I, PKC beta II and PKC epsilon. Prolonged stimulation of GqPCRs has been shown to decrease IKs membrane expression, but the specific role of each PKC isoform is unclear. Here we show that stimulation of calcium-dependent isoforms of PKC (cPKC) but not PKC epsilon mimic receptor activation. In addition, we show that general PKC beta (LY-333531) and PKC beta II inhibitors but not PKC alpha or PKC beta I inhibitors blocked the effect of cPKC on the KCNQ1/KCNE1 channel. PKC beta inhibitors also blocked GqPCR-mediated decrease in channel membrane expression in cardiomyocytes. Direct activation of PKC beta II using constitutively active PKC beta II construct mimicked agonist-induced decrease in membrane expression and channel function, while dominant negative PKC beta II showed no effect. This suggests that the KCNQ1/KCNE1 channel was not regulated by basal levels of PKC beta II activity. Our results indicate that PKC beta II is a specific regulator of IKs membrane localization. PKC beta II expression and activation are strongly increased in many disease states, including heart disease and diabetes. Thus, our results suggest that PKC beta II inhibition may protect against acquired QT prolongation associated with heart disease.
机译:慢电压门控钾通道(IKS)由KCNQ1和KCNE1亚基组成,是心脏中的主要复极电流之一。蛋白激酶C(PKC)的活化与心律失常有关。尽管PKC已被证明是许多心脏通道的调节因子,包括IKS,几乎是通过PKC的特异性同种型调节通道的。在这里,我们研究了不同PKC同种型对IKS频道膜定位和功能的作用。我们的研究重点是PKC同种型,响应于GQ偶联受体(GQPCR)刺激(GQPCR)刺激:PKCα,PKCβ1,PKCβII和PKC epsilon。已经显示GQPCR的延长刺激降低了IK膜表达,但每种PKC同种型的特定作用尚不清楚。在这里,我们表明刺激PKC(CPKC)的钙依赖性同种型,但不是PKCεIMIC受体激活。此外,我们表明一般PKCβ(LY-333531)和PKCβII抑制剂,但不是PKCα或PKCβI抑制剂阻断CPKC对KCNQ1 / KCNE1通道的影响。 PKCβ抑制剂还阻断了心肌细胞中的沟道膜表达的GQPCR介导的降低。使用组成型活性PKCβII构建体模拟的激动剂诱导的膜表达和通道功能的直接激活PKCβII,而显性阴性PKCβII没有效果。这表明KCNQ1 / KCNE1通道未受PKCβII活性的基础水平调节。我们的结果表明,PKCβII是IK膜定位的特定调节因子。在许多疾病状态下,PKCβII表达和活化强烈增加,包括心脏病和糖尿病。因此,我们的结果表明PKCβII抑制可以防止与心脏病相关的获得性QT延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号